The Food and Drug Administration this week approved expanded labeling for Janssen Biotech’s rheumatoid arthritis treatment Simponi Aria (golimumab for infusion).
Pfizer said that the transaction has strengthened the company’s branded and generics portfolio, particularly when it comes to biosimilars.
Lupin Pharmaceuticals on Thursday announced the launch of its duloxetine delayed-release, a generic version of Cymbalta.
J.D. Power’s annual U.S. Pharmacy Study has ranked AmerisourceBergen’s Good Neighbor Pharmacy network the highest in customer satisfaction among chain drug stores.
Bayer HealthCare on Thursday announced that it will sponsor community awareness efforts nationwide this September, in honor of Prostate Cancer Awareness Month.
A year after deciding to end tobacco sales, CVS Health on Thursday released new data from a CVS Health Research Institute study that shows a reduction in cigarette purchases over the past year.
California state Sen. Jeff Stone, a former independent pharmacist himself, had one message for independent pharmacists during the McKesson ideaShare 2015 Public Policy session in San Diego — don’t just vote, get involved.
The drug, a biosimilar version of Amgen’s Neupogen, is the first biosimilar drug to launch in the U.S.
Kmart has paid the U.S. government $1.4 million to resolve allegations that it improperly used drug manufacturer coupons and gasoline discounts to reduce pharmacy costs for Medicare patients at Kmart pharmacies.
Walgreens kicked off its third Get a Shot. Give a Shot campaign on Wednesday. This year’s campaign promises to provide a life-saving vaccine for every immunization administered at any Walgreens pharmacy, Healthcare Clinic or Duane Reade until Aug. 31, 2016.